Two thiouronium iodide salts,(E)-2-methyl-1,3-diphenylisothiouronium iodide(1) and 1,3-dibenzyl-2-methylisothiouronium iodide(2),were synthesized and characterized by single-crystal X-ray diffraction,1H NMR,IR,U...Two thiouronium iodide salts,(E)-2-methyl-1,3-diphenylisothiouronium iodide(1) and 1,3-dibenzyl-2-methylisothiouronium iodide(2),were synthesized and characterized by single-crystal X-ray diffraction,1H NMR,IR,UV-vis and luminescence spectra.Single-crystal X-ray diffraction reveals that compound 1 crystallizes in monoclinic system,P21/n space group with a = 11.273(2),b = 10.318(2),c = 12.962(3) A,β = 99.03(3)°,V = 1489.0(5) A^3 and Z = 4;compound 2 crystallizes in monoclinic system,C2/c space group with a = 11.706(2),b = 14.119(3),c = 20.930(4) A,β = 103.84(3)°,V = 3358.8(12) A^3 and Z = 8.The thiouroniums of both compounds are Y-shaped planar structures to form a cross-conjugated system.The averaged bond lengths of C-N and C-S indicate the presence of "Y" aromaticity.The researches on UV-vis and luminescence spectra of compounds 1 and 2 indicate that they can form inclusion complex with β-CD in the aqueous solution.展开更多
<span style="font-family:Verdana;">A series of novel substituted benzimidazole </span><b><span style="font-family:Verdana;">(7a</span></b><b><span style...<span style="font-family:Verdana;">A series of novel substituted benzimidazole </span><b><span style="font-family:Verdana;">(7a</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">n)</span></b><span style="font-family:Verdana;"> derivatives w</span><span style="font-family:Verdana;">ere</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> synthesized and characterized by </span><sup><span style="font-family:Verdana;">1</span></sup><span style="font-family:Verdana;">H, </span><sup><span style="font-family:Verdana;">13</span></sup><span style="font-family:Verdana;">C Nuclear Magnetic Resonance (NMR) spectra and High Resolution Mass Spectrometry (HRMS). The substitution w</span></span><span style="font-family:Verdana;">as</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> done in position -1 and -2 by appropriate groups. These compounds are obtained by N-alkylation reaction with thiomethyl-1</span><i><span style="font-family:Verdana;">H</span></i><span style="font-family:Verdana;">-benzimidazole intermediates </span><b><span style="font-family:Verdana;">(5a</span></b></span><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">g)</span></b><span style="font-family:;" "=""><span style="font-family:Verdana;">. Design of intermediates </span><b><span style="font-family:Verdana;">(5a</span></b></span><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">g)</span></b><span style="font-family:;" "=""><span style="font-family:Verdana;"> was made by condensation reaction between 2-methylbenzimidazole thiourunium salt </span><b><span style="font-family:Verdana;">(3)</span></b><span style="font-family:Verdana;"> and functionalized halides </span><b><span style="font-family:Verdana;">(4)</span></b><span style="font-family:Verdana;"> in the presence of sodium hydroxide (NaOH). Among the </span><span style="font-family:Verdana;">twenty-one compounds synthesized, ten were evaluated for their antimi</span><span style="font-family:Verdana;">crobial activity on three bacterial strains namely: </span><i><span style="font-family:Verdana;">Escherichia</span></i> <i><span style="font-family:Verdana;">coli</span></i><span style="font-family:Verdana;"> ATCC 25922, </span><i><span style="font-family:Verdana;">Staphylococcus</span></i> <i><span style="font-family:Verdana;">aureus</span></i><span style="font-family:Verdana;"> ATCC 25923 and </span><i><span style="font-family:Verdana;">Pseudomonas</span></i> <i><span style="font-family:Verdana;">aeruginosa</span></i><span style="font-family:Verdana;"> ATCC 27853. Only </span><i><span style="font-family:Verdana;">E.</span></i> <i><span style="font-family:Verdana;">coli</span></i><span style="font-family:Verdana;"> ATTC 25922 was susceptible to the synthesized derivatives </span><b><span style="font-family:Verdana;">5g</span></b><span style="font-family:Verdana;">, </span><b><span style="font-family:Verdana;">7f</span></b><span style="font-family:Verdana;"> and </span><b><span style="font-family:Verdana;">7h</span></b><span style="font-family:Verdana;"> with a significant antibacterial activity (CMI </span></span><span style="font-family:Verdana;">is </span><span style="font-family:Verdana;">between 250 and 500 μg/mL)</span><span style="font-family:Verdana;">.</span>展开更多
基金the financial support of the National Natural Science Foundation of China(No.21101062,21271068,21203059)Educational Commission of Hubei Province(No.Q21021402)+1 种基金Chutian Scholar Fund of Hubei Province(No.4032401)National Training Programs of Innovation and Entrepreneurship for Undergraduates(No.201210500012)
文摘Two thiouronium iodide salts,(E)-2-methyl-1,3-diphenylisothiouronium iodide(1) and 1,3-dibenzyl-2-methylisothiouronium iodide(2),were synthesized and characterized by single-crystal X-ray diffraction,1H NMR,IR,UV-vis and luminescence spectra.Single-crystal X-ray diffraction reveals that compound 1 crystallizes in monoclinic system,P21/n space group with a = 11.273(2),b = 10.318(2),c = 12.962(3) A,β = 99.03(3)°,V = 1489.0(5) A^3 and Z = 4;compound 2 crystallizes in monoclinic system,C2/c space group with a = 11.706(2),b = 14.119(3),c = 20.930(4) A,β = 103.84(3)°,V = 3358.8(12) A^3 and Z = 8.The thiouroniums of both compounds are Y-shaped planar structures to form a cross-conjugated system.The averaged bond lengths of C-N and C-S indicate the presence of "Y" aromaticity.The researches on UV-vis and luminescence spectra of compounds 1 and 2 indicate that they can form inclusion complex with β-CD in the aqueous solution.
文摘<span style="font-family:Verdana;">A series of novel substituted benzimidazole </span><b><span style="font-family:Verdana;">(7a</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">n)</span></b><span style="font-family:Verdana;"> derivatives w</span><span style="font-family:Verdana;">ere</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> synthesized and characterized by </span><sup><span style="font-family:Verdana;">1</span></sup><span style="font-family:Verdana;">H, </span><sup><span style="font-family:Verdana;">13</span></sup><span style="font-family:Verdana;">C Nuclear Magnetic Resonance (NMR) spectra and High Resolution Mass Spectrometry (HRMS). The substitution w</span></span><span style="font-family:Verdana;">as</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> done in position -1 and -2 by appropriate groups. These compounds are obtained by N-alkylation reaction with thiomethyl-1</span><i><span style="font-family:Verdana;">H</span></i><span style="font-family:Verdana;">-benzimidazole intermediates </span><b><span style="font-family:Verdana;">(5a</span></b></span><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">g)</span></b><span style="font-family:;" "=""><span style="font-family:Verdana;">. Design of intermediates </span><b><span style="font-family:Verdana;">(5a</span></b></span><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">g)</span></b><span style="font-family:;" "=""><span style="font-family:Verdana;"> was made by condensation reaction between 2-methylbenzimidazole thiourunium salt </span><b><span style="font-family:Verdana;">(3)</span></b><span style="font-family:Verdana;"> and functionalized halides </span><b><span style="font-family:Verdana;">(4)</span></b><span style="font-family:Verdana;"> in the presence of sodium hydroxide (NaOH). Among the </span><span style="font-family:Verdana;">twenty-one compounds synthesized, ten were evaluated for their antimi</span><span style="font-family:Verdana;">crobial activity on three bacterial strains namely: </span><i><span style="font-family:Verdana;">Escherichia</span></i> <i><span style="font-family:Verdana;">coli</span></i><span style="font-family:Verdana;"> ATCC 25922, </span><i><span style="font-family:Verdana;">Staphylococcus</span></i> <i><span style="font-family:Verdana;">aureus</span></i><span style="font-family:Verdana;"> ATCC 25923 and </span><i><span style="font-family:Verdana;">Pseudomonas</span></i> <i><span style="font-family:Verdana;">aeruginosa</span></i><span style="font-family:Verdana;"> ATCC 27853. Only </span><i><span style="font-family:Verdana;">E.</span></i> <i><span style="font-family:Verdana;">coli</span></i><span style="font-family:Verdana;"> ATTC 25922 was susceptible to the synthesized derivatives </span><b><span style="font-family:Verdana;">5g</span></b><span style="font-family:Verdana;">, </span><b><span style="font-family:Verdana;">7f</span></b><span style="font-family:Verdana;"> and </span><b><span style="font-family:Verdana;">7h</span></b><span style="font-family:Verdana;"> with a significant antibacterial activity (CMI </span></span><span style="font-family:Verdana;">is </span><span style="font-family:Verdana;">between 250 and 500 μg/mL)</span><span style="font-family:Verdana;">.</span>